Endocrine Tumors of the Gut and Pancreas Tumor Biology and Classification
- 1 October 2004
- journal article
- review article
- Published by S. Karger AG in Neuroendocrinology
- Vol. 80 (Suppl. 1) , 12-15
- https://doi.org/10.1159/000080733
Abstract
The endocrine tumors of the gut and pancreas tract are a group of neoplasms composed of cells with a neuroendocrine phenotype. Well-differentiated tumors, well-differentiated carcinomas and poorly differentiated carcinomas are the major categories identified. According to their localization (stomach, duodenum-jejunum, ileum, appendix and colorectum), they display distinct phenotypes, regarding their pathology, immunohistochemistry and hormonal syndromes. Their clinical behavior spans from benign, uncertain malignant potential, low-grade malignant to high-grade malignant. Currently, extensive work is performed to unravel the genetic background.Keywords
This publication has 13 references indexed in Scilit:
- The “Normal” Endocrine Cell of the Gut: Changing Concepts and New EvidencesAnnals of the New York Academy of Sciences, 2004
- The Gastroenteropancreatic Neuroendocrine Cell System and Its Tumors: The WHO ClassificationAnnals of the New York Academy of Sciences, 2004
- Highlights of the biology of endocrine tumours of the gut and pancreas.Endocrine-Related Cancer, 2003
- Prognostic Factors in Pancreatic Endocrine Neoplasms: An Analysis of 136 Cases With a Proposal for Low-Grade and Intermediate-Grade GroupsJournal of Clinical Oncology, 2002
- ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: Prognostic evaluation by pathological analysisGastroenterology, 1999
- Prognostic criteria in nonfunctioning pancreatic endocrine tumoursVirchows Archiv, 1996
- Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: A comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variablesHuman Pathology, 1996
- Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesiclesCell, 1985
- PGP 9.5, a new marker for human neuroendocrine tumoursHistopathology, 1985
- Specific Endocrine Tissue Marker Defined by a Monoclonal AntibodyScience, 1983